RecruitingNCT06965322
Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
Prospective Observational Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
Sponsor
Medical University Innsbruck
Enrollment
800 participants
Start Date
Nov 11, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manifestations, a comprehensive range of functional and clinical evaluations will be performed and correlated with structural lung assessments using computed tomography (CT).
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patients ≥18 years diagnosed with rheumatoid arthritis according to current ACR/EULAR criteria
- Residence in Austria
- Signed and dated consent of the patient in accordance with ICH-GCP guidelines
Exclusion Criteria3
- pregnancy
- age below 18 years
- Contraindications to study-related routine examinations (e.g., inability to draw blood due to needle phobia, no CT scan possible due to claustrophobia, pregnancy, etc.)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06965322
Related Trials
Intervention to Support Partners and Informal Caregivers of Frail RA-patients
NCT074427731 location
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
NCT048066201 location
Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.
NCT070893811 location
Biomarkers in Inflammatory Rheumatic Diseases Diagnosis
NCT067783431 location